1st-of-its-kind therapy blocks immune attack after stem-cell transplant

[admin]

A midstage clinical trial suggests that a "first-of-its-kind" treatment could prevent serious immune attacks from bone-marrow transplants.

1st-of-its-kind therapy blocks immune attack after stem-cell transplant : Read more